Literature DB >> 20157307

Environmental factors and their timing in adult-onset multiple sclerosis.

Adam E Handel1, Gavin Giovannoni, George C Ebers, Sreeram V Ramagopalan.   

Abstract

Multiple sclerosis (MS) is a common, complex neurological disease. Epidemiological data implicate both genetic and environmental factors in the etiology of MS, with various factors interacting with one another. Environmental exposures might occur long before the disease becomes clinically evident, as suggested by the wide range in onset age. In this Review, we examine the key time periods during which the environment might contribute to MS susceptibility, as well as the potential environmental factors involved. Understanding the nature of environmental influences in MS is highly relevant to the development of public health measures that are aimed at preventing this debilitating disease.

Entities:  

Mesh:

Year:  2010        PMID: 20157307     DOI: 10.1038/nrneurol.2010.1

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  145 in total

1.  Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle.

Authors:  M T Kampman; T Wilsgaard; S I Mellgren
Journal:  J Neurol       Date:  2007-03-21       Impact factor: 4.849

2.  Multiple sclerosis after infectious mononucleosis.

Authors:  Trine Rasmussen Nielsen; Klaus Rostgaard; Nete Munk Nielsen; Nils Koch-Henriksen; Sven Haahr; Per Soelberg Sørensen; Henrik Hjalgrim
Journal:  Arch Neurol       Date:  2007-01

3.  Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis.

Authors:  I Grant; G W Brown; T Harris; W I McDonald; T Patterson; M R Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

Review 4.  Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection.

Authors:  Meytal Avgil; Asher Ornoy
Journal:  Reprod Toxicol       Date:  2005-01-08       Impact factor: 3.143

5.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Authors:  Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

Review 6.  The epidemiology of autoimmune diseases.

Authors:  Glinda S Cooper; Berrit C Stroehla
Journal:  Autoimmun Rev       Date:  2003-05       Impact factor: 9.754

7.  Emotional stress and the development of multiple sclerosis: case-control evidence of a relationship.

Authors:  S Warren; S Greenhill; K G Warren
Journal:  J Chronic Dis       Date:  1982

8.  Oral contraceptives and reproductive factors in multiple sclerosis incidence.

Authors:  L Villard-Mackintosh; M P Vessey
Journal:  Contraception       Date:  1993-02       Impact factor: 3.375

9.  Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Authors:  Sreeram V Ramagopalan; Narelle J Maugeri; Lahiru Handunnetthi; Matthew R Lincoln; Sarah-Michelle Orton; David A Dyment; Gabriele C Deluca; Blanca M Herrera; Michael J Chao; A Dessa Sadovnick; George C Ebers; Julian C Knight
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

Review 10.  Demyelination: the role of reactive oxygen and nitrogen species.

Authors:  K J Smith; R Kapoor; P A Felts
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

View more
  77 in total

Review 1.  Vaccination against infection in patients with multiple sclerosis.

Authors:  Micha Loebermann; Alexander Winkelmann; Hans-Peter Hartung; Hartmut Hengel; Emil C Reisinger; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

2.  Smoking: effects on multiple sclerosis susceptibility and disease progression.

Authors:  Dean M Wingerchuk
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

3.  UV radiation, vitamin D, and multiple sclerosis.

Authors:  Lahiru Handunnetthi; Sreeram V Ramagopalan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-04       Impact factor: 11.205

Review 4.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Human skin pigmentation, migration and disease susceptibility.

Authors:  Nina G Jablonski; George Chaplin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

Review 6.  Do We Need Worms to Promote Immune Health?

Authors:  Joel V Weinstock
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

7.  An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.

Authors:  Adam E Handel; Alexander J Williamson; Giulio Disanto; Lahiru Handunnetthi; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

8.  The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions.

Authors:  Adam E Handel; Lynne Jarvis; Ryan McLaughlin; Anastasia Fries; George C Ebers; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

9.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 10.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.